JPH019556Y2 - - Google Patents
Info
- Publication number
- JPH019556Y2 JPH019556Y2 JP1984050226U JP5022684U JPH019556Y2 JP H019556 Y2 JPH019556 Y2 JP H019556Y2 JP 1984050226 U JP1984050226 U JP 1984050226U JP 5022684 U JP5022684 U JP 5022684U JP H019556 Y2 JPH019556 Y2 JP H019556Y2
- Authority
- JP
- Japan
- Prior art keywords
- taping
- shoulder
- elasticity
- weight
- adhesive layer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000853 adhesive Substances 0.000 claims description 19
- 230000001070 adhesive effect Effects 0.000 claims description 19
- 239000012790 adhesive layer Substances 0.000 claims description 18
- 239000000463 material Substances 0.000 claims description 17
- 238000004804 winding Methods 0.000 claims description 7
- 238000000034 method Methods 0.000 description 16
- -1 N-substituted acrylamide Chemical class 0.000 description 8
- 239000004744 fabric Substances 0.000 description 8
- 239000011347 resin Substances 0.000 description 7
- 229920005989 resin Polymers 0.000 description 7
- LVYLCBNXHHHPSB-UHFFFAOYSA-N 2-hydroxyethyl salicylate Chemical compound OCCOC(=O)C1=CC=CC=C1O LVYLCBNXHHHPSB-UHFFFAOYSA-N 0.000 description 6
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 6
- 229920001971 elastomer Polymers 0.000 description 6
- 244000043261 Hevea brasiliensis Species 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000002655 kraft paper Substances 0.000 description 5
- 229920003052 natural elastomer Polymers 0.000 description 5
- 229920001194 natural rubber Polymers 0.000 description 5
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 4
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 4
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 4
- 210000003041 ligament Anatomy 0.000 description 4
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 229920001296 polysiloxane Polymers 0.000 description 4
- GOXQRTZXKQZDDN-UHFFFAOYSA-N 2-Ethylhexyl acrylate Chemical compound CCCCC(CC)COC(=O)C=C GOXQRTZXKQZDDN-UHFFFAOYSA-N 0.000 description 3
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 description 3
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 description 3
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 239000003522 acrylic cement Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 239000000806 elastomer Substances 0.000 description 3
- 229960002389 glycol salicylate Drugs 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000000123 paper Substances 0.000 description 3
- 238000007665 sagging Methods 0.000 description 3
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 description 3
- 239000011787 zinc oxide Substances 0.000 description 3
- YBYIRNPNPLQARY-UHFFFAOYSA-N 1H-indene Chemical compound C1=CC=C2CC=CC2=C1 YBYIRNPNPLQARY-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 2
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 2
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000010894 electron beam technology Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 230000005865 ionizing radiation Effects 0.000 description 2
- 230000001678 irradiating effect Effects 0.000 description 2
- 229920003049 isoprene rubber Polymers 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 229940041616 menthol Drugs 0.000 description 2
- 229960001047 methyl salicylate Drugs 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 239000004745 nonwoven fabric Substances 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 229920001568 phenolic resin Polymers 0.000 description 2
- 239000005011 phenolic resin Substances 0.000 description 2
- 239000004014 plasticizer Substances 0.000 description 2
- 229920001083 polybutene Polymers 0.000 description 2
- 150000003097 polyterpenes Chemical class 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 229920002994 synthetic fiber Polymers 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- RDJGLLICXDHJDY-NSHDSACASA-N (2s)-2-(3-phenoxyphenyl)propanoic acid Chemical compound OC(=O)[C@@H](C)C1=CC=CC(OC=2C=CC=CC=2)=C1 RDJGLLICXDHJDY-NSHDSACASA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- IANQTJSKSUMEQM-UHFFFAOYSA-N 1-benzofuran Chemical compound C1=CC=C2OC=CC2=C1 IANQTJSKSUMEQM-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- KXGFMDJXCMQABM-UHFFFAOYSA-N 2-methoxy-6-methylphenol Chemical compound [CH]OC1=CC=CC([CH])=C1O KXGFMDJXCMQABM-UHFFFAOYSA-N 0.000 description 1
- VSKJLJHPAFKHBX-UHFFFAOYSA-N 2-methylbuta-1,3-diene;styrene Chemical compound CC(=C)C=C.C=CC1=CC=CC=C1.C=CC1=CC=CC=C1 VSKJLJHPAFKHBX-UHFFFAOYSA-N 0.000 description 1
- IYLLULUTZPKQBW-UHFFFAOYSA-N Acrinol Chemical compound CC(O)C(O)=O.C1=C(N)C=CC2=C(N)C3=CC(OCC)=CC=C3N=C21 IYLLULUTZPKQBW-UHFFFAOYSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- 208000010392 Bone Fractures Diseases 0.000 description 1
- 229920004939 Cariflex™ Polymers 0.000 description 1
- 229920000298 Cellophane Polymers 0.000 description 1
- DBAKFASWICGISY-BTJKTKAUSA-N Chlorpheniramine maleate Chemical compound OC(=O)\C=C/C(O)=O.C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 DBAKFASWICGISY-BTJKTKAUSA-N 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- 206010050031 Muscle strain Diseases 0.000 description 1
- CMWTZPSULFXXJA-UHFFFAOYSA-N Naproxen Natural products C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 229920001328 Polyvinylidene chloride Polymers 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- IDCBOTIENDVCBQ-UHFFFAOYSA-N TEPP Chemical compound CCOP(=O)(OCC)OP(=O)(OCC)OCC IDCBOTIENDVCBQ-UHFFFAOYSA-N 0.000 description 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 229960004892 acemetacin Drugs 0.000 description 1
- FSQKKOOTNAMONP-UHFFFAOYSA-N acemetacin Chemical compound CC1=C(CC(=O)OCC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 FSQKKOOTNAMONP-UHFFFAOYSA-N 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 125000005250 alkyl acrylate group Chemical group 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229960002504 capsaicin Drugs 0.000 description 1
- 235000017663 capsaicin Nutrition 0.000 description 1
- 229940007061 capsicum extract Drugs 0.000 description 1
- 239000001943 capsicum frutescens fruit extract Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 229940046978 chlorpheniramine maleate Drugs 0.000 description 1
- 210000003109 clavicle Anatomy 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 229960000520 diphenhydramine Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229960001419 fenoprofen Drugs 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 230000009477 glass transition Effects 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- 210000001503 joint Anatomy 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- DKYWVDODHFEZIM-UHFFFAOYSA-N ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 description 1
- 229960000991 ketoprofen Drugs 0.000 description 1
- YMBXTVYHTMGZDW-UHFFFAOYSA-N loxoprofen Chemical compound C1=CC(C(C(O)=O)C)=CC=C1CC1C(=O)CCC1 YMBXTVYHTMGZDW-UHFFFAOYSA-N 0.000 description 1
- 229960002373 loxoprofen Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 230000009525 mild injury Effects 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- XFHJDMUEHUHAJW-UHFFFAOYSA-N n-tert-butylprop-2-enamide Chemical compound CC(C)(C)NC(=O)C=C XFHJDMUEHUHAJW-UHFFFAOYSA-N 0.000 description 1
- 229960002009 naproxen Drugs 0.000 description 1
- CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000011088 parchment paper Substances 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 229960002702 piroxicam Drugs 0.000 description 1
- QYSPLQLAKJAUJT-UHFFFAOYSA-N piroxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=CC=CC=N1 QYSPLQLAKJAUJT-UHFFFAOYSA-N 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229920006255 plastic film Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000005033 polyvinylidene chloride Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 208000037974 severe injury Diseases 0.000 description 1
- 230000009528 severe injury Effects 0.000 description 1
- 239000004447 silicone coating Substances 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000000021 stimulant Substances 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000012209 synthetic fiber Substances 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 238000009864 tensile test Methods 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
- 239000002759 woven fabric Substances 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
Description
【考案の詳細な説明】
本考案は、打撲、捻挫、脱臼、骨折、肉離れの
如き、骨、筋肉、関節等の障害を治療し、或いは
予防するのに使用するテーピング用具に関連し、
殊に本考案は、人体の肩部分に適用されるテーピ
ング用具に関する。[Detailed description of the invention] The present invention relates to a taping tool used to treat or prevent disorders of bones, muscles, joints, etc. such as bruises, sprains, dislocations, fractures, and muscle strains.
In particular, the present invention relates to a taping device applied to the shoulder region of the human body.
従来この種障害の治療や予防には、障害部位へ
ギブス、サポータ等の保護具を装着することが一
般に行なわれる。例えばギブスの場合、障害部位
を完全固定する構造であるため、骨折等の重度障
害の治療に有効であるが、適度な運動が許容され
る中度乃至軽度の障害の治療には適さない。また
サポータの場合、障害部位の圧迫作用により内出
血やはれを押える等の効果を期待できるが、障害
部位の動きを規制する作用がなく、障害部位の保
護機能を全く欠いている。そこで近年、障害部位
へ粘着テープを貼付し若しくは巻き付けるテーピ
ングという技法が注目されるに至つた。このテー
ピング技法は、障害部位の動きを適度に規制で
き、而もその規制度合を障害の種類や症状に応じ
て適宜調節できる利点がある。ところがこの技法
を用いるには、専門的且つ熟練した技能の修得が
必要であるため、一般の者がこのテーピング技法
を利用することは殆んど困難であつた。そこで先
般、足の部分に対して一般の者でも簡易にテーピ
ング技法を実施できるテーピング用具が提案され
た(特開昭57−66777号および特開昭58−155879
号)。これらのテーピング用具は、一方表面に粘
着層を有するシート材を足部分に対応する特定の
形状に裁断して形成されるもので、前記粘着層を
足部分に当ててテーピング用具を貼付することに
より、足部分を固定するものである。しかしなが
ら従来のテーピング用具は、適用部位が足のよう
な特定部分に限られており、他の身体部位に適用
されるものは全く存在しない。しかも従来のもの
は、その形状的な工夫をもつて、簡易なテーピン
グ技法を実現することのみを狙いとしているた
め、テーピングの性能が十分でなく、特にテーピ
ング技法に必要な患部を固定したり締め付けたり
する作用が乏しいため、障害等の部位を十分に保
護できず、加えて貼付部分に力が作用すると、簡
単に剥離するなどの問題があつた。 Conventionally, in order to treat or prevent this type of disorder, it is common practice to attach protective equipment such as a cast or a supporter to the affected area. For example, a cast has a structure that completely fixes the affected area, so it is effective in treating severe injuries such as bone fractures, but it is not suitable for treating moderate to mild injuries that allow moderate exercise. In addition, in the case of a supporter, it can be expected to have the effect of suppressing internal bleeding or swelling by compressing the injured area, but it does not have the effect of regulating the movement of the injured area and completely lacks the function of protecting the injured area. Therefore, in recent years, a technique called taping, in which adhesive tape is pasted or wrapped around the affected area, has attracted attention. This taping technique has the advantage that the movement of the affected area can be moderately controlled, and the degree of regulation can be adjusted as appropriate depending on the type and symptoms of the disorder. However, since this taping technique requires the acquisition of specialized and skilled skills, it has been difficult for ordinary people to use this taping technique. Therefore, a taping tool was recently proposed that allows even the general public to easily perform taping techniques on the foot (Japanese Patent Application Laid-Open Nos. 57-66777 and 58-155879).
issue). These taping tools are formed by cutting a sheet material that has an adhesive layer on one surface into a specific shape corresponding to the foot part, and by applying the adhesive layer to the foot part and pasting the taping tool. , which fixes the foot part. However, conventional taping tools can only be applied to specific parts such as the feet, and there are no taping tools that can be applied to other body parts. Moreover, the conventional taping techniques are only designed to realize simple taping techniques with their innovative shapes, so the taping performance is not sufficient, especially for fixing and tightening the affected area, which is necessary for taping techniques. Because of its poor protective effect, it was unable to adequately protect the area affected by the injury, and it also had problems such as being easily peeled off when force was applied to the area to which it was applied.
本考案は、テーピングの性能には、形状の他に
シート材の伸縮性や粘着層の接着力が関与してい
ることに着目したもので、肩部分へテーピング技
法を適用するに最適な形状な工夫すると共に、シ
ート材の伸縮性と粘着層の接着力とを最適状態に
設定することにより、肩部分に対しテーピング技
法を簡易に実施し得かつ十分なテーピングの性能
を得ることのできる新規な肩用テーピング用具を
提供することを目的とする。 This invention focuses on the fact that the performance of taping is affected not only by the shape but also by the elasticity of the sheet material and the adhesive strength of the adhesive layer. By devising new methods and optimizing the elasticity of the sheet material and the adhesive strength of the adhesive layer, we have developed a new method that allows taping to be performed easily on the shoulder area and provides sufficient taping performance. The purpose of the present invention is to provide a shoulder taping tool.
以下図面に示す実施例に基づき本考案を具体的
に説明する。 The present invention will be specifically described below based on embodiments shown in the drawings.
第1図は肩部分(図中、一点鎖線で示す)に適
用される本考案のテーピング用具を示す。このテ
ーピング用具は、皮膚表面へ全面貼付する構造の
ものであつて、支え片1の上端部および下端部に
両側方へ真直に突出する止め固定片2,3およ
び、巻き固定片4,5を一連に形成すると共に、
上下の各固定片2,4、3,5間に円曲形状のく
びれ部6,7を形成して成る。支え片1は、上端
縁10と下端縁11とが互いに平行し且つ水平状
となつており、上端縁10の中央部を鎖骨上部に
位置させ、支え片1の全長を肩の傾斜に沿わせた
とき、くびれ部6,7より上部が肩部に、また下
部が上腕部に対応位置する。更にくびれ部6,7
は、肩と腕の形状に対応させ、且つ脇の前後部を
完全に回避する曲率並びに深さに形成されるもの
で、これにより腕の上下運動が全く阻止されない
ようになつている。前記止め固定片2,3は、そ
の一方が胸部の乳房上部位置に止着固定され、他
方が背部の肩甲部に止着固定される。各止め固定
片2,3の下辺縁21,31は滑らかな曲線をも
つてくびれ部6,7と連続しており、この曲線は
腕の丸みに沿う形状となつている。前記巻き固定
片4,5は、これを上腕部に巻き付け、各先端部
を脇下方位置で対向させて止着固定する。このよ
うに支え片1の上下端縁10,11を水平状とな
し、また上下端部両側に止め固定片2,3およ
び、巻き固定片4,5を設けて、その間にくびれ
部6,7を形成することにより、テーピング用具
全体が肩部乃至上腕部の形状や凹凸に完全適合す
る。 FIG. 1 shows the taping tool of the present invention applied to a shoulder portion (indicated by a chain line in the figure). This taping tool has a structure to be applied to the entire surface of the skin, and has fastening pieces 2 and 3 that project straight to both sides at the upper and lower ends of the supporting piece 1, and winding fixing pieces 4 and 5. Along with forming a series,
Circular constrictions 6, 7 are formed between the upper and lower fixing pieces 2, 4, 3, 5. The support piece 1 has an upper edge 10 and a lower edge 11 parallel to each other and is horizontal, with the center of the upper edge 10 positioned above the clavicle, and the entire length of the support piece 1 aligned with the slope of the shoulder. When the waist is bent, the upper portion of the waist portions 6 and 7 corresponds to the shoulder portion, and the lower portion corresponds to the upper arm portion. Furthermore, the constrictions 6, 7
is formed with a curvature and depth that corresponds to the shapes of the shoulders and arms and completely avoids the front and rear areas of the armpits, so that the vertical movement of the arms is not inhibited at all. One of the fastening pieces 2 and 3 is fastened to the upper part of the breast on the chest, and the other is fastened to the shoulder blade on the back. The lower edges 21 and 31 of each stopper and fixing piece 2 and 3 have a smooth curve and are continuous with the constricted portions 6 and 7, and this curve has a shape that follows the roundness of the arm. The winding and fixing pieces 4 and 5 are wound around the upper arm and fastened and fixed with their tips facing each other at a position below the armpit. In this way, the upper and lower edges 10 and 11 of the support piece 1 are made horizontal, and the fixing pieces 2 and 3 and the winding fixing pieces 4 and 5 are provided on both sides of the upper and lower ends, and the constricted parts 6 and 7 are provided between them. By forming this, the entire taping tool perfectly adapts to the shape and irregularities of the shoulder and upper arm.
上記形状のテーピング用具は、肩部分の靭帯や
筋肉を固定して、その動きを制限するためのもの
であり、従つて縦方向(矢印aで示す)の伸縮性
は伸縮率が50%以下であるよう規制される。また
直交する横方向(矢印bで示す)については、伸
縮性を有する方が好ましく、50%以上の伸縮率に
設定するもので、これにより肩ないしは上腕への
固定力が強化されると共に、体の動きに順応でき
る等の顕著な効果がある。 The taping tool of the above shape is used to fix the ligaments and muscles in the shoulder area and restrict their movement, so the elasticity in the vertical direction (indicated by arrow a) must be less than 50%. be regulated as such. In addition, in the orthogonal lateral direction (indicated by arrow b), it is preferable to have elasticity, and the elasticity should be set to 50% or more.This strengthens the fixation force on the shoulder or upper arm, and It has remarkable effects such as being able to adapt to the movements of people.
第2図は上記テーピング用具の断面構造を示
し、テープ基材8の一方表面に粘着層80が形成
され、この粘着層80上に剥離材9が貼付してあ
る。シート基材8は、布地、不織布、紙、合成樹
脂膜、発泡体等の強靭なシート材が採択され、好
ましくは布地や不織布、特に好ましくは布地を使
用する。布地の場合、その原料は絹、毛等の天然
繊維、スフ、ビスコース等の人造繊維、ナイロ
ン、テトロン、アクリル、ウレタン等の合成繊
維、若しくはこれらの混合繊維等が用いられ、シ
ート基材8の強度として15Kg/2.5cm以上、更に
好ましくは30Kg/2.5cm以上が必要である(強度
は日本工業規格の織物の引張試験方法に準じて測
定)。粘着層80の生成には、アクリル系粘着剤
若しくはゴム系粘着剤のいずれかひとつ若しくは
これらの混合物が用いられる。アクリル系粘着剤
の場合、これを構成する主成分として一般に炭素
原子数4〜8個のアルキル基を有するアクリル酸
アルキルエステルがあげられ、更にこのアクリル
酸アルキルエステルは、アクリル酸ブチル、アク
リル酸n−オクチル、アクリル酸2−エチルヘキ
シル等のアクリル酸アルキルに、酢酸ビニル、ア
クリル酸メチル、メタクリル酸メチル等のガラス
転移点の高い単量体と、アクリル酸、メタクリル
酸、アクリルアミド、N−置換アクリルアミド、
ヒドロキシアルキルアクリレート等の官能基を有
する単量体とを共重合させて生成される。このう
ちアクリル酸アルキルは全重量に対し50重量%以
上を配合する必要があり、50重量%以下では十分
な粘接着力が得られないこととなる。尚イソシア
ネート系、エポキシ系、ユリア系等の反応性の高
い硬化処理剤、或いはX線、γ線、電子線等の電
離性放射線を照射して硬化する方法等を用いて、
前記粘着成分のバランスをとることも可能であ
る。一方ゴム系粘着剤の場合は、NR、SBR、
SIS、SBS、IR、IIR等のエラストマーがあげら
れ、更に粘着力を付与するため、ロジン、ロジン
変性樹脂、ポリテルペン系樹脂、脂肪族芳香族石
油樹脂、フエノール系樹脂、クマロンインデン系
樹脂、キシレン系樹脂、スチレン系樹脂等の粘着
付与剤を配合し、更に粘着基剤をバランスよく保
持するため、流動パラフイン、ポリブテン等の石
油系可塑剤、大豆油、ゴマ油、オリーブ油、椿油
等の植物系可塑剤、酸化亜鉛、酸化チタン、炭酸
カルシウム、ホワイトカーボン、カオリン等の充
填剤を適宜配合してもよい。更にはイオウ、過酸
化物等を配合し、或いはX線、γ線、電子線等の
電離性放射線を照射して、架橋処理を行なつても
よく、また必要に応じて老化防止剤、酸化防止剤
を配合してもよい。そしてこれらの配合量は、エ
ラストマー100重量部に対し、粘着付与剤を25
〜300重量部、好ましくは50〜250重量部、更に好
ましくは110〜200重量部配合する。尚粘着付与剤
が300重量部以上では、エラストマーの弾性的性
質が著しく低下し、皮膚表面からの剥離時に強い
痛みを与えたり、皮膚に粘着成分が残つたりす
る。 FIG. 2 shows a cross-sectional structure of the above-mentioned taping tool, in which an adhesive layer 80 is formed on one surface of the tape base material 8, and a release material 9 is pasted on this adhesive layer 80. As the sheet base material 8, a strong sheet material such as cloth, nonwoven fabric, paper, synthetic resin film, foam, etc. is adopted, and preferably cloth or nonwoven fabric is used, and cloth is particularly preferably used. In the case of fabric, raw materials include natural fibers such as silk and wool, artificial fibers such as cotton wool and viscose, synthetic fibers such as nylon, Tetron, acrylic, and urethane, or mixed fibers thereof. The strength is required to be 15 kg/2.5 cm or more, more preferably 30 kg/2.5 cm or more (strength is measured according to the Japanese Industrial Standards textile tensile test method). To form the adhesive layer 80, either an acrylic adhesive or a rubber adhesive, or a mixture thereof is used. In the case of acrylic adhesives, the main component thereof is generally an acrylic acid alkyl ester having an alkyl group having 4 to 8 carbon atoms. - alkyl acrylates such as octyl and 2-ethylhexyl acrylate, monomers with high glass transition points such as vinyl acetate, methyl acrylate, and methyl methacrylate, and acrylic acid, methacrylic acid, acrylamide, N-substituted acrylamide,
It is produced by copolymerizing with a monomer having a functional group such as hydroxyalkyl acrylate. Of these, alkyl acrylate must be blended in an amount of 50% by weight or more based on the total weight; if it is less than 50% by weight, sufficient adhesive strength will not be obtained. In addition, using highly reactive curing agents such as isocyanate-based, epoxy-based, and urea-based, or methods of curing by irradiating with ionizing radiation such as X-rays, γ-rays, and electron beams,
It is also possible to balance the adhesive components. On the other hand, in the case of rubber adhesives, NR, SBR,
Examples include elastomers such as SIS, SBS, IR, and IIR, and for additional adhesive strength, rosin, rosin-modified resins, polyterpene resins, aliphatic aromatic petroleum resins, phenolic resins, coumaron indene resins, and xylene. In addition, in order to maintain the adhesive base in a well-balanced manner, we use petroleum-based plasticizers such as liquid paraffin and polybutene, and vegetable-based plasticizers such as soybean oil, sesame oil, olive oil, and camellia oil. fillers, such as zinc oxide, titanium oxide, calcium carbonate, white carbon, and kaolin, may be appropriately blended. Furthermore, crosslinking treatment may be performed by adding sulfur, peroxide, etc., or irradiating with ionizing radiation such as X-rays, γ-rays, and electron beams. An inhibitor may also be added. The amount of these compounds is 25 parts by weight of tackifier per 100 parts by weight of elastomer.
~300 parts by weight, preferably 50 to 250 parts by weight, more preferably 110 to 200 parts by weight. If the amount of the tackifier exceeds 300 parts by weight, the elastic properties of the elastomer will be significantly reduced, causing severe pain when peeled from the skin surface, or leaving adhesive components on the skin.
かくしてテーピング用具の接着力特性は、フエ
ノール樹脂板に対する180゜ピール接着力として
200g/18mm以上、好ましくは400g/18mm、更に
好ましくは600g/18mm以上に設定し、またせん
断接着力としては2Kg/18mm以上、好ましくは5
Kg/18mm以上、更に好ましくは10Kg/18mm以上に
設定する。尚、180゜ピール接着力が200g/18mmよ
り小さい場合や、せん断接着力が2Kg/18mmより
小さい場合は、皮膚に対するテーピング用具の固
定が弱くなり、剥離し易くなる。 Thus, the adhesive strength of the taping tool is expressed as the 180° peel adhesive strength to the phenolic resin plate.
Set to 200g/18mm or more, preferably 400g/18mm, more preferably 600g/18mm or more, and the shear adhesive strength is 2Kg/18mm or more, preferably 5
Kg/18mm or more, more preferably 10Kg/18mm or more. In addition, if the 180° peel adhesive force is less than 200 g/18 mm or the shear adhesive force is less than 2 kg/18 mm, the fixation of the taping tool to the skin becomes weak and it becomes easy to peel off.
上記の粘着層80には、必要に応じて皮膚刺激
剤、消炎鎮痛剤等の薬効成分を配合してもよい。
例えば薬効成分として、サリチル酸メチル、サリ
チル酸グリコール、サリチル酸、メントール、ハ
ツカ油、カンフル、チモール、アクリノール、ロ
ートエキス、マレイン酸クロルフエニラミン、ジ
フエンヒドラミン、ニコチン酸ベンジルエステ
ル、トウガラシエキス、ノニル酸バニリルアミ
ド、カプサイシン、イブプロフエン、インドメタ
シン、アルクロフエナツク、ケトプロフエン、フ
ロバイプロフエン、フエノプロフエン、ナプロキ
セン、ピロキシカム、アセメタシン、クリダナツ
ク、ロキソプロフエンおよびこれらのエステル
類、コルチコステロイド類等から1種または2種
以上を選択使用する。これら薬効成分の配合量は
薬剤100重量部に対し0.01〜20重量部が適当であ
る。更に経皮吸収促進剤、安定剤、香料、鉱油、
角質軟化剤、抗ヒスタミン剤等を適宜配合しても
よい。 The adhesive layer 80 may contain medicinal ingredients such as skin stimulants and anti-inflammatory analgesics, if necessary.
For example, medicinal ingredients include methyl salicylate, glycol salicylate, salicylic acid, menthol, peppermint oil, camphor, thymol, acrinol, rhoto extract, chlorpheniramine maleate, diphenhydramine, benzyl nicotinic acid ester, capsicum extract, vanillyl nonylic acid. , capsaicin, ibuprofen, indomethacin, alklofenac, ketoprofen, flobiprofen, fenoprofen, naproxen, piroxicam, acemetacin, clidanuc, loxoprofen and esters thereof, corticosteroids, etc. Select and use. The appropriate amount of these medicinal ingredients is 0.01 to 20 parts by weight per 100 parts by weight of the drug. In addition, transdermal absorption enhancers, stabilizers, fragrances, mineral oil,
A keratin emollient, an antihistamine, etc. may be added as appropriate.
更に剥離材9については、シリコンコーテイン
グ等の剥離処理を施こしたクラフト紙、クラシン
紙、パーチメント紙等の紙や、ポリエチレン、ポ
リプロピレン、ポリエステル、ポリ塩化ビニル、
ポリ塩化ビニリデン、ポリスチレン等のプラスチ
ツクフイルムや、セロフアンのいずれかを選択し
て用いる。尚テーピング用具の全面には、多数の
通気孔を開設してもよく、これにより気触れ等の
皮膚炎を防止でき、また汗が貯留して剥離するの
を阻止する効果がある。 Further, as for the release material 9, paper such as kraft paper, Krashin paper, parchment paper, etc., which has been subjected to release treatment such as silicone coating, polyethylene, polypropylene, polyester, polyvinyl chloride, etc.
A plastic film such as polyvinylidene chloride, polystyrene, or cellophane is selected and used. Note that a large number of ventilation holes may be provided on the entire surface of the taping tool, which has the effect of preventing dermatitis such as skin irritation and preventing sweat from accumulating and peeling off.
つぎに配合組成の具体例を挙げると、以下のと
おりである。 Next, specific examples of the composition are as follows.
〔実施例 1〕
アクリル酸2−エチルヘキシル72重量%、酢酸
ビニル23重量%、メタアクリル酸3重量%及び過
酸化ベンゾイル2重量%を50〜70℃にて共重合し
て得られたアクリル系粘着剤をトルエン溶剤中固
形分濃度25%になるよう溶解し、この溶解液を直
交方向の伸縮率が133%、上下方向の伸縮率が30
%のポリウレタン織布に厚さ200μ(wet)に展延
し、乾燥炉(80〜120℃)を通し粘着層を形成し、
その上ヘシリコンをコーテイング処理したクラフ
ト紙を剥離剤として貼付した。[Example 1] Acrylic adhesive obtained by copolymerizing 72% by weight of 2-ethylhexyl acrylate, 23% by weight of vinyl acetate, 3% by weight of methacrylic acid, and 2% by weight of benzoyl peroxide at 50 to 70°C. The agent was dissolved in toluene solvent to a solid concentration of 25%, and this solution had a stretching ratio of 133% in the orthogonal direction and a stretching ratio of 30% in the vertical direction.
% polyurethane woven fabric to a thickness of 200μ (wet) and passed through a drying oven (80-120℃) to form an adhesive layer.
On top of that, kraft paper coated with silicone was pasted as a release agent.
〔実施例 2〕
アクリル酸2−エチルヘキシル68.42部、酢酸
ビニル21.05部及びN−tert−ブチルアクリルアミ
ド10.53部を50〜70℃にて共重合して得られたア
クリル系粘着剤95重量%、l−メントール3重量
%及びサリチル酸グリコール2重量%をトルエン
溶剤中固形分濃度30%になるよう溶解し、この溶
解液を実施例1と同じ布地に、同一方法条件にて
展延して粘着層を形成した。[Example 2] Acrylic adhesive obtained by copolymerizing 68.42 parts of 2-ethylhexyl acrylate, 21.05 parts of vinyl acetate, and 10.53 parts of N-tert-butylacrylamide at 50 to 70°C, 95% by weight, l- 3% by weight of menthol and 2% by weight of glycol salicylate were dissolved in a toluene solvent to a solid concentration of 30%, and this solution was spread on the same fabric as in Example 1 under the same method conditions to form an adhesive layer. did.
〔実施例 3〕
NR(天然ゴム)33重量%、ポリテルペン樹脂
33重量%、液状イソプレンラバー16重量%、酸化
亜鉛18重量%を混練機にて混合均一分散し、次に
温度70〜90℃のカレダーロールにて実施例1と同
じ布地に厚さ50μに展延して粘着層を形成し、そ
の上へシリコンをコーテイング処理したクラフト
紙を剥離材として貼付した。[Example 3] NR (natural rubber) 33% by weight, polyterpene resin
33% by weight of liquid isoprene rubber, 16% by weight of liquid isoprene rubber, and 18% by weight of zinc oxide were mixed and dispersed uniformly using a kneader, and then spread on the same fabric as in Example 1 to a thickness of 50 μm using a calendar roll at a temperature of 70 to 90°C. An adhesive layer was formed, and kraft paper coated with silicone was pasted thereon as a release material.
〔実施例 4〕
NR(天然ゴム)30重量%、ロジン変性樹脂27
重量%、ポリブテン15重量%、酸化亜鉛23重量
%、l−メントール3重量%、サリチル酸メチル
2重量%を混練機にて混合均一分散し、次に温度
70〜90℃のカレダーロールにて実施例1と同じ布
地に厚さ50μに展延して粘着層を形成し、その上
ヘシリコンをコーテイング処理したクラフト紙を
剥離材として貼付した。[Example 4] NR (natural rubber) 30% by weight, rosin modified resin 27
% by weight, 15% by weight of polybutene, 23% by weight of zinc oxide, 3% by weight of l-menthol, and 2% by weight of methyl salicylate were mixed and dispersed uniformly in a kneader, and then the temperature
An adhesive layer was formed by rolling the same fabric as in Example 1 to a thickness of 50 μm using a calender roll at 70 to 90° C., and kraft paper coated with silicone was pasted thereon as a release material.
〔実施例 5〕
SIS(スチレン−イソプレン−スチレンラバ
ー:シエル化学製カリフレツクスTR−1107)24
重量%、ロジン変性樹脂48重量%、流動パラフイ
ン18重量%、酸化チタン5重量%、l−メントー
ル3重量%、サリチル酸グリコール2重量%を温
度120〜160℃の混合機に溶融均一混合し、この溶
融液をリバースロールコーターにて実施例1と同
じ布地に厚さ50μに展延して粘着層を形成し、そ
の上ヘシリコンをコーテイング処理したクラフト
紙を剥離材として貼付した。[Example 5] SIS (styrene-isoprene-styrene rubber: Ciel Chemical Co., Ltd. CARIFLEX TR-1107) 24
% by weight, 48% by weight of rosin modified resin, 18% by weight of liquid paraffin, 5% by weight of titanium oxide, 3% by weight of l-menthol, and 2% by weight of glycol salicylate were melted and mixed uniformly in a mixer at a temperature of 120 to 160°C. The melt was spread on the same fabric as in Example 1 to a thickness of 50 μm using a reverse roll coater to form an adhesive layer, and kraft paper coated with silicone was pasted thereon as a release material.
然して剥離材9を除いて粘着層80を露出させ
た状態で、支え片1を治療若しくは予防にかかる
肩から上腕に至る部位へ貼付する。この場合、ま
ず巻き固定片4,5の方を上腕部に巻き付けて止
着固定した後、上腕部を持ち上げ且つ吊り上げる
状態にして、支え片1を貼付してゆくと共に、各
止め固定片2,3を胸部および背部にて止着固定
する。上記の巻き固定片4,5や止め固定片2,
3は、これを両側へ引張り伸張させながら、而も
たるみやしわを生じさせないように所定部位へ止
着するものである。尚上記装着に際して、従来公
知の貼付剤または湿布剤を患部に貼付し、その上
から本考案のテーピング用具を装着してもよい。
上記手順にてテーピング用具を両肩に装着する
と、本考案の形状によれば、第3図乃至第5図に
示す如く、支え片1は肩鎖靭帯、鳥口鎖、骨靭
帯、三角筋、関節乞上に正しく位置し、而も全体
が肩部分の形状に完全適合するものであり、特に
端部等においてしわやたるみの発生がない。 With the release material 9 removed and the adhesive layer 80 exposed, the support piece 1 is applied to the area from the shoulder to the upper arm that is to be treated or prevented. In this case, first, the winding fixing pieces 4 and 5 are wrapped around the upper arm and fixed, and then the upper arm is lifted and suspended, and the supporting piece 1 is attached, and each of the fixing pieces 2, 3 is fixed on the chest and back. The above winding fixing pieces 4, 5 and stop fixing pieces 2,
3 is for fixing it to a predetermined location while stretching it to both sides, without causing any sagging or wrinkles. Incidentally, in the above-mentioned installation, a conventionally known patch or poultice may be applied to the affected area, and the taping tool of the present invention may be applied thereon.
When the taping tools are attached to both shoulders in the above procedure, according to the shape of the present invention, as shown in FIGS. It is positioned correctly on the joint, and the whole part perfectly conforms to the shape of the shoulder part, and there are no wrinkles or sagging, especially at the ends.
かかる貼付状態において、支え片1は縦方向の
伸縮が規制されるから、靭帯や筋肉を固定する働
き、すなわち靭帯等が上下方向に伸びようとする
のを制限する。また全体がたるむことなく肩部分
に適合しているから、ねじれ方向に対しても運動
の制限阻止力が作用する。更に一方において、く
びれ部6,7が上腕基端部に対応位置するから、
腕の上下運動は何等阻外されない。更に本考案は
テーピング技法によるXサポートと縦サポートを
結合させた形状となつており、テーピング理論に
も合致しているものである。 In this attached state, the supporting piece 1 is restricted from expanding and contracting in the vertical direction, so it serves to fix the ligaments and muscles, that is, it restricts the ligaments from stretching in the vertical direction. In addition, since the entire body fits the shoulder area without sagging, a force that restricts movement acts in the torsional direction as well. Furthermore, on the one hand, since the constrictions 6 and 7 are located corresponding to the proximal end of the upper arm,
The vertical movement of the arm is not hindered in any way. Furthermore, the present invention has a shape that combines an X support and a vertical support using the taping technique, and is consistent with the taping theory.
本考案は上記の如く、シート材の形状を肩部分
へテーピングを適用するのに最適な形状に工夫す
ると共に、シート材の伸縮性と粘着層の接着力と
を最適状態に設定したから、これを肩部より上腕
部にかけて貼付するだけで、一般人と雖もテーピ
ング技法を肩部分に簡易に実施できる。しかも全
体が肩部分に沿つて適合して、肩部の筋肉や靭帯
等を固定するため、その動きを有効かつ適度に制
限でき、加えて貼付部分に力が作用しても粘着層
は容易に剥離せず、肩部分における障害を確実に
保護し、また予防することができる。 As mentioned above, the present invention was developed by devising the shape of the sheet material to be optimal for applying taping to the shoulder area, and by optimizing the elasticity of the sheet material and the adhesive strength of the adhesive layer. By simply pasting it from the shoulder to the upper arm, ordinary people can easily apply the taping technique to the shoulder area. Moreover, since the entire body conforms to the shoulder area and fixes the muscles and ligaments in the shoulder area, their movement can be effectively and moderately restricted, and in addition, even if force is applied to the attachment part, the adhesive layer will not easily adhere to the shoulder area. It does not peel off and can reliably protect and prevent injuries in the shoulder area.
また全体が単純な形状であるから、これを工業
生産する場合、材料の無駄が生じず、また取扱い
が容易であり、製造コストを低減できる等、幾多
の顕著な効果を奏する。 In addition, since the overall shape is simple, when it is industrially produced, there is no wastage of materials, it is easy to handle, and it has many remarkable effects such as reducing manufacturing costs.
第1図は本考案にかかるテーピング用具の平面
図、第2図はその断面図、第3図はテーピング用
具の装着状況を示す正面図、第4図はその背面
図、第5図は右側面図である。
1……支え片、10……上端縁、11……下端
縁、2,3……止め固定片、4,5……巻き固定
片、6,7……くびれ部。
Fig. 1 is a plan view of the taping tool according to the present invention, Fig. 2 is a sectional view thereof, Fig. 3 is a front view showing how the taping tool is installed, Fig. 4 is a rear view thereof, and Fig. 5 is a right side view. It is a diagram. 1... Support piece, 10... Upper edge, 11... Lower edge, 2, 3... Stop fixing piece, 4, 5... Winding fixing piece, 6, 7... Narrow part.
Claims (1)
て形成された肩部に適用されるテーピング用具で
あつて、 平行かつ水平状をなす上端縁と下端縁とを備え
て上下端縁間の縦方向の長さを肩より上腕に至る
長さに対応させた支え片と、支え片の上端部を両
側方へ真直に突出させた肩部の前後で止着固定さ
れる止め固定片と、支え片の下端部を両側方へ真
直に突出させた上腕に巻き付けて止着固定される
巻き固定片とが一連に形成されると共に、上下の
各固定片間には脇の前後部を回避する曲率および
深さを有する円曲形状のくびれ部が形成されてお
り、 前記シート材の伸縮性は、縦方向の伸縮率を50
%以下に設定して伸縮性を規制しかつ横方向の伸
縮率を50%以上に設定して伸縮性を付与すると共
に、前記粘着層の接着力は、180゜ピール接着力を
200g/18mm以上に、せん断接着力を2Kg/18mm
以上に、それぞれ設定して成る肩用テーピング用
具。[Claims for Utility Model Registration] A taping tool applied to a shoulder formed of a strong sheet material with an adhesive layer on one surface, the upper and lower edges of which are parallel and horizontal. There is a supporting piece whose vertical length between the upper and lower edges corresponds to the length from the shoulder to the upper arm, and the upper end of the supporting piece is fixed at the front and back of the shoulder part that protrudes straight to both sides. The lower end of the supporting piece is wrapped around the upper arm that projects straight to both sides, and a winding fixing piece is formed in a series. A circular constriction with a curvature and depth that avoids the front and rear of the armpit is formed, and the elasticity of the sheet material is such that the elasticity in the longitudinal direction is 50%.
% or less to regulate elasticity, and set the lateral elasticity to 50% or more to impart elasticity, and the adhesive force of the adhesive layer is 180° peel adhesive force.
200g/18mm or more, shear adhesive strength 2Kg/18mm
The shoulder taping equipment is made up of the above settings.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5022684U JPS60160819U (en) | 1984-04-04 | 1984-04-04 | Shoulder taping equipment |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5022684U JPS60160819U (en) | 1984-04-04 | 1984-04-04 | Shoulder taping equipment |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS60160819U JPS60160819U (en) | 1985-10-25 |
JPH019556Y2 true JPH019556Y2 (en) | 1989-03-16 |
Family
ID=30568160
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP5022684U Granted JPS60160819U (en) | 1984-04-04 | 1984-04-04 | Shoulder taping equipment |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS60160819U (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3442423B2 (en) * | 1992-06-05 | 2003-09-02 | 積水化学工業株式会社 | Simple corset and simple corset stuck body |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS529823U (en) * | 1975-07-09 | 1977-01-24 | ||
JPS5766777A (en) * | 1980-10-15 | 1982-04-23 | Kuniaki Yamazaki | Protective tool for arch |
JPS58155879A (en) * | 1983-02-25 | 1983-09-16 | 中島 紀久男 | Taping tool |
-
1984
- 1984-04-04 JP JP5022684U patent/JPS60160819U/en active Granted
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS529823U (en) * | 1975-07-09 | 1977-01-24 | ||
JPS5766777A (en) * | 1980-10-15 | 1982-04-23 | Kuniaki Yamazaki | Protective tool for arch |
JPS58155879A (en) * | 1983-02-25 | 1983-09-16 | 中島 紀久男 | Taping tool |
Also Published As
Publication number | Publication date |
---|---|
JPS60160819U (en) | 1985-10-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10292945B2 (en) | Dressings that contain active substance | |
AU784779B2 (en) | Ultraviolet-shielding adhesive preparation | |
JP4873871B2 (en) | Adhesives and patches | |
US20050208115A1 (en) | Multi-purpose combined drug delivery and heat therapy treatment system | |
JP4660858B2 (en) | Transdermal preparation | |
WO2006017632A1 (en) | An analgesic patch for sports injury and rehabilitation medicine and method to alleviate pain | |
US20070053966A1 (en) | Medicated orthopedic support structures for treatment of damaged musculoskeletal tissue | |
US20220023425A1 (en) | Stretchable backing layers for transdermal drug delivery systems | |
JPH019553Y2 (en) | ||
JP2009191038A (en) | Stretchable patch | |
JPH019554Y2 (en) | ||
JPH019556Y2 (en) | ||
JPH019555Y2 (en) | ||
WO2006018340A1 (en) | Active agent-containing plaster strip for treating joint diseases | |
JPH019552Y2 (en) | ||
JPH0119936Y2 (en) | ||
JPH019551Y2 (en) | ||
JPH019557Y2 (en) | ||
JP2018029859A (en) | Joint-part patch | |
JPH0212984Y2 (en) | ||
JP3550242B2 (en) | Patch for alleviating menstrual pain symptoms | |
JP2581041Y2 (en) | Adhesive tape | |
JPH06145047A (en) | Hydrous skin patch for external use having improved utility | |
JPH11255635A (en) | Patch for sole | |
EP0198003A1 (en) | Cough-relieving compositions |